Eversense 365 is widely available by insurance for people taking insulin
Eversense 365 is covered by the majority of commercial health plans.
Experience the Eversense 365 CGM system for as low as $199 for a full year. This includes the cost of both CGM sensor and transmitter.*
Eversense 365 is available for those with Medicare.†
Unfortunately, Eversense CGM Systems are not covered by Medicaid or Medi-Cal at this time.
Eversense can be paid for out-of-pocket. For the most accurate price, please get in touch with us.
Getting Started Is Simple
A short, in-office procedure is all it takes for more peace of mind over your diabetes management. Get started in a few simple steps.
Frequently Asked Questions
If you have insurance, your out of pocket cost will vary depending on your coverage and plan. If interested & qualified, we'd run a benefit investigation with your insurance company to confirm the cost.
If you're on commercial insurance, we have the PASS program that means you could pay as low as $199 for a full year. This includes the cost of both CGM sensor and transmitter.*
If you don't have insurance, call us at (945) 221-9068 to discuss cash-pay options.
An Eversense Expert can help! After your eligibility is confirmed, we’ll answer any questions you may have, assist you in locating an Eversense Inserter nearby, and determine the cost based on your insurance. We’ll submit the claim to your insurance provider and work directly with your health care provider and a distribution partner to order your Eversense CGM.
We will remain in contact with you via email every step of the way.
Yes, insurance may cover both the product (sensor and transmitter) and the insertion and removal procedures. However every situation is different, so we recommend you get in touch via our pre-qualify form and an Eversense Expert can confirm what insurance covers for you and what out-of-pocket costs you may have.
Download our discussion guide and bring it to your next appointment and talk to your doctor about how Eversense may be a better fit for your diabetes management plan. We will work with you and your health care provider to manage your insurance claim.
Our pre-qualification form will ask you a few questions about your diabetes type, therapy and your current insurance provider - this will allow us to tell you what your insurance may cover for Eversense. Our Eversense Expert will then get in touch with you to confirm your details and submit the claim to your insurance provider and work directly with your health care provider and a distribution partner to order your Eversense CGM.
See why people are choosing
Eversense.
Learn more about the experiences of Eversense users whose lives were changed after switching to a long-term CGM.
Want to see if you
qualify?
Our short quiz will ask about your insurance coverage, your insulin usage, and what benefits you’re looking for in a CGM.
If you’re ready, click below and let’s see if Eversense is right for you.
* Offer does not apply to the insertion and removal procedures. The Eversense PASS Program has limitations on eligibility. See website (bit.ly/EversensePass) for more details. Ascensia Diabetes Care reserves the right to change or terminate this program at any time without notice. The program benefit is capped per transaction. There may be instances in which patient out-of-pocket costs exceed what is detailed in the offer. Eversense E3 is not eligible for the PASS Program.
† Speak to an Eversense Expert for more information on Medicare coverage.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-US-0059